Get the Stockscreener App
10.78
8.67%
0.86
Exagen Inc stock is traded at $10.78, with a volume of 372.29K.
It is up +8.67% in the last 24 hours and up +6.73% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$9.92
Open:
$10.09
24h Volume:
372.29K
Relative Volume:
1.40
Market Cap:
$237.20M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-11.47
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+17.56%
1M Performance:
+6.73%
6M Performance:
+166.17%
1Y Performance:
+254.61%
1-Day Range:
$10.05
$10.83
1-Week Range:
$9.1485
$10.83
52-Week Range:
$2.38
$10.83
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
10.78 | 218.28M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
468.00 | 177.38B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
185.91 | 135.85B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
627.17 | 51.87B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
124.38 | 35.70B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
181.24 | 31.70B | 15.70B | 1.24B | 2.01B | 6.91 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Can volume confirm reversal in Exagen Inc.Treasury Yields & Stepwise Trade Signal Guides - newser.com
Long term hold vs stop loss in Exagen Inc.Trade Analysis Summary & Short-Term High Return Strategies - newser.com
What MACD signals say about Exagen Inc.Jobs Report & Growth Oriented Trading Recommendations - newser.com
Can Exagen Inc. recover in the next quarterWeekly Trend Summary & Daily Price Action Insights - newser.com
Merger Talk: Will Exagen Inc benefit from current market trendsJuly 2025 Sentiment & Technical Pattern Based Buy Signals - خودرو بانک
Research Analysts Set Expectations for Exagen Q3 Earnings - MarketBeat
Signal strength of Exagen Inc. stock in tech scannersInsider Selling & Technical Entry and Exit Tips - newser.com
How hedge fund analytics apply to Exagen Inc. stockEarnings Summary Report & Free Weekly Chart Analysis and Trade Guides - newser.com
Can Exagen Inc. hit a new high this monthOptions Play & Step-by-Step Trade Execution Guides - newser.com
Rate Cut: Is Exagen Inc impacted by rising ratesJuly 2025 Review & Real-Time Volume Trigger Notifications - khodrobank.com
Exagen Inc. recovery potential after sell offJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
Can a trend reversal in Exagen Inc. lead to recoveryJuly 2025 Drop Watch & Low Drawdown Investment Strategies - newser.com
Earnings Risk: Is Exagen Inc exposed to political riskCEO Change & Detailed Earnings Play Strategies - خودرو بانک
What MACD and RSI say about Exagen Inc.Portfolio Profit Report & Real-Time Volume Trigger Notifications - newser.com
Using Python tools to backtest Exagen Inc. strategiesJuly 2025 Review & Technical Pattern Recognition Alerts - newser.com
Sectors Review: Why is Cassava Sciences Inc. Equity Warrant stock going downPortfolio Update Summary & High Return Trade Guides - خودرو بانک
B. Riley Begins Coverage on Exagen (NASDAQ:XGN) - MarketBeat
Patterns Watch: Is Exagen Inc. a turnaround storyJuly 2025 Market Mood & Reliable Intraday Trade Plans - خودرو بانک
Is Exagen Inc. stock entering bullish territory2025 Pullback Review & Capital Efficient Trade Techniques - newser.com
Momentum Shift: Can Exagen Inc maintain sales growthJuly 2025 Chart Watch & AI Based Buy/Sell Signal Reports - خودرو بانک
Aug Opening: Why is Exagen Inc. stock going downJuly 2025 Pullbacks & Reliable Price Breakout Alerts - خودرو بانک
Fed Watch: Is Exagen Inc benefiting from innovation trendsJuly 2025 Trade Ideas & Real-Time Buy Signal Notifications - خودرو بانک
ETF Watch: Will Exagen Inc benefit from current market trendsPortfolio Return Summary & Entry and Exit Point Strategies - khodrobank.com
Exagen (NASDAQ:XGN) Now Covered by B. Riley - MarketBeat
Trading Recap: Can Exagen Inc. be the next market leaderPrice Action & Community Verified Trade Signals - khodrobank.com
Aug Rallies: Is Exagen Inc impacted by rising ratesTrade Volume Report & Weekly High Return Stock Forecasts - خودرو بانک
Exagen Inc. (NASDAQ:XGN) Receives $11.25 Consensus PT from Brokerages - MarketBeat
What is B. Riley’s Forecast for Exagen Q3 Earnings? - Defense World
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):